The company whose name is synonymous with aspirin is looking for a speedy remedy for stagnant sales.
Scientists at Bayer Consumer Care headquarters in New Jersey worked for five years to address consumers' No. 1 complaint: That the aspirin doesn't work fast enough to relieve pain.
So on Monday, Bayer is introducing a reformulated aspirin that it says works in half the time of regular aspirin.
Dubbed Pro-Release Technology, it uses aspirin micro-particles about a tenth the size of those in standard Bayer in tablets that dissolve and enter the bloodstream much more quickly.
Bayer says its aspirin is now better-known for preventing heart attack and stroke than for its pain reliever roots. Bayer says it needs to revitalize the brand and target younger customers.
Copyright 2015 by The Associated Press. All Rights Reserved.